ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
2018 · Molecular Cancer Therapeutics · 138 citations
https://doi.org/10.1158/1535-7163.mct-16-0847
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
84
Papers
1.8K
Citations
20
h-index
21
i10-index
Manikandan Periyasamy is an academic researcher from American College, Madurai. The author has contributed to research in topics: Cancer-related Molecular Pathways & Advanced Breast Cancer Therapies & Hippo pathway signaling and YAP/TAZ. The author has an h-index of 20, co-authored 72 publications.
ORCID: 0000-0001-7626-2531https://doi.org/10.1158/1535-7163.mct-16-0847
https://doi.org/10.1186/bcr1891
Click to start Chat